Site icon Wire Centre

India US Trade Talks India Issues Blunt Ultimatum To US Over Tariffs, Stating ‘No Deal Better Than A Bad Deal’

India US Trade Talks  India Issues Blunt Ultimatum To US Over Tariffs, Stating 'No Deal Better Than A Bad Deal'

India US Trade Talks India Issues Blunt Ultimatum To US Over Tariffs, Stating 'No Deal Better Than A Bad Deal'

 

Wire Centre

India US Trade Talks India has sent a clear and uncompromising message to the United States regarding their ongoing trade deliberations, firmly stating that “no deal is better than a bad deal.” The bold declaration comes as negotiations for the muchanticipated IndiaUS Bilateral Trade Agreement (BTA) face severe gridlock. While the Trump administration views the economic partnership through a strict lens of reducing India’s trade surplus, New Delhi has made it clear that it will not sacrifice the core interests of its domestic manufacturers and farmers. The friction has intensified following unilateral US actions, including proposed Section 301 tariffs of up to 40.5% linked to controversial industrial capacity and labor probes. Representing India’s stance, commerce ministry officials have openly questioned the legal and evidentiary basis of these punitive measures, challenging Washington to resolve differences through mutual diplomatic dialogue rather than highhanded public coercion. Despite the strategic necessity of aligning against regional economic challenges, India’s firm pushback underscores its refusal to enter into an unequal trade framework that compromises its economic sovereignty.

India US Trade Talks – New Delhi Rejects Washington’s Unilateral Pressures in Trade Pact Negotiations

The trade relationship between India and the United States has hit a major rocky patch, with New Delhi slowing down the pace of negotiations to send a stern message to Washington. Amid escalating friction over new economic boundaries, top Indian trade officials have made it clear that they are fully prepared to walk away from the table, coining the stance that “no deal is better than a bad deal.” The friction points are centered on America’s aggressive use of its new regulatory playbook, which seeks to extract deep market concessions from India while simultaneously implementing rolling punitive measures. Indian negotiators have firmly resisted these tactics, asserting that while a deeper economic alliance is mutually beneficial, India will not accept an unbalanced partnership that puts its domestic industries at an unfair disadvantage.

India US Trade Talks – Massive Tariff Hikes and Coercive Tactics Stale Historic Bilateral Agreement

The underlying trigger for India’s sharp diplomatic pivot is a series of aggressive investigations launched under Section 301 of the US Trade Act. The US Trade Representative (USTR) panel recently proposed adding hefty tariffs ranging from 10% to 12.5% onto existing baselines, which could skyrocket the total effective tariff burden on key Indian exports to a staggering 40.5%. Washington has tied these penalties to sweeping, generalized allegations regarding forced labor and industrial overcapacity across dozens of nations. Appearing before a public hearing, Brij Mohan Mishra, Joint Secretary in India’s Ministry of Commerce, strongly challenged the legal basis of these claims. He pointed out massive inconsistencies in the US framework—such as the USTR granting exemptions to 1,600 domestic products—and noted there is zero evidence linking major Indian export sectors to unfair labor practices.

India US Trade Talks – Defending the Annadata- India Refuses to Yield on Agricultural and Digital Autonomy

Beyond the immediate tariff disputes, the negotiations remain deeply deadlocked over critical sectors like agriculture, technology, and pharmaceuticals. The Trump administration has placed heavy pressure on India to eliminate or slash import duties on a wide array of US food products, animal feed, and medical devices. However, Indian leadership has maintained an ironclad boundary, stating it will never allow the genuine livelihood and survival of the Indian farmer to be compromised to satisfy Western corporate interests. Furthermore, local industry representatives, including the Federation of Indian Chambers of Commerce and Industry (FICCI), have warned that accepting excessively rigid Western patent regimes or digital infrastructure rules could cripple India’s booming generic drug sector and lock its data ecosystem into permanent foreign dependence, hurting consumers and businesses on both sides.

👉 Also Read:
Revanth Reddy Controversy Telangana Politics Explodes After CM Revanth Reddy’s Violent “Blood on Crops” Remark Against BRS

Exit mobile version